You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 3, 2024

VISIPAQUE 320 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Visipaque 320, and what generic alternatives are available?

Visipaque 320 is a drug marketed by Ge Healthcare and is included in two NDAs.

The generic ingredient in VISIPAQUE 320 is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Visipaque 320

A generic version of VISIPAQUE 320 was approved as iodixanol by HENGRUI PHARMA on May 19th, 2022.

  Try a Trial

Drug patent expirations by year for VISIPAQUE 320
Recent Clinical Trials for VISIPAQUE 320

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Liver and Biliary Sciences, IndiaN/A
University of WashingtonPhase 1
GuerbetPhase 1

See all VISIPAQUE 320 clinical trials

Pharmacology for VISIPAQUE 320

US Patents and Regulatory Information for VISIPAQUE 320

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare VISIPAQUE 320 iodixanol INJECTABLE;INJECTION 020351-002 Mar 22, 1996 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ge Healthcare VISIPAQUE 320 iodixanol INJECTABLE;INJECTION 020808-002 Aug 29, 1997 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VISIPAQUE 320

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare VISIPAQUE 320 iodixanol INJECTABLE;INJECTION 020808-002 Aug 29, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ge Healthcare VISIPAQUE 320 iodixanol INJECTABLE;INJECTION 020351-002 Mar 22, 1996 ⤷  Try a Trial ⤷  Try a Trial
Ge Healthcare VISIPAQUE 320 iodixanol INJECTABLE;INJECTION 020351-002 Mar 22, 1996 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VISIPAQUE 320

See the table below for patents covering VISIPAQUE 320 around the world.

Country Patent Number Title Estimated Expiration
Denmark 508283 ⤷  Try a Trial
German Democratic Republic 295992 KONTRASTMITTEL ⤷  Try a Trial
Russian Federation 2088261 КОНТРАСТНОЕ СРЕДСТВО ДЛЯ АНГИОГРАФИИ КОРОНАРНЫХ СОСУДОВ И СПОСОБ ЕГО ПОЛУЧЕНИЯ (RADIOPAQUE MEANS AND METHOD FOR CARRYING OUT ANGIOGRAPHIC EXAMINATION OF CORONARY VESSELS) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for VISIPAQUE 320

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0108638 97C0101 Belgium ⤷  Try a Trial PRODUCT NAME: IODIXANOL; NAT. REGISTRATION NO/DATE: 914 IS 204 F 12 19970325; FIRST REGISTRATION: SE 11758 19930205
0108638 SPC/GB93/150 United Kingdom ⤷  Try a Trial SPC/GB93/150, 20031107, EXPIRES: 20080330
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.